Bioprocess Control is a market leader in the area of low gas volume and flow analytical instruments for biotechnology related applications. The company was founded in 2006 and today brings to market nearly 20 years of industry leading research and product development in the area of smart analytical instruments. Bioprocess Control currently has customers in over 60 countries and regions around the world with more added every year.
Today, Bioprocess Control's portfolio include, among other things, their two flagship products: the Automatic Methane Potential Test System (AMPTS), which has become the preferred analytical instrument for conducting various anaerobic batch fermentation tests, as well as the Gas Endeavour; a novel analytical platform for bacteria respiration analysis and biological batch fermentation assays in both anaerobic and aerobic conditions.
Providing a plethora of benefits, these automated analytical devices galvanise efficient, cost-effective operations, due to the reduction in time and labour. extremely user-friendly and accessible remotely, the meticulously collected data can be reached whenever it is required. Moreover, these automated analytical devices provide standardised measurements, data and reports, delivering clear, comparable information on which evidence-based decisions can be made.
To bring to market innovative low gas flow analytical instruments that allow for more efficient and higher quality research and analysis, leading to significant reductions in time and labour.
To become a global leader in low gas flow analytical instruments for a broad range of research and commercial applications across multiple industries.
We invest in innovation and the development of smart instruments, ensure the highest product quality throughout our portfolio, and focus on being service minded and always meeting the needs of our customers.